PSTV — Plus Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $6.84m
- $5.34m
- $4.91m
- 25
- 30
- 33
- 19
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 17.6 | 8.35 | 18.4 | 18.1 | 8.55 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.31 | 0 | — | — | — |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 19.8 | 9.18 | 19.7 | 21.8 | 9.83 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.96 | 2.46 | 1.82 | 1.57 | 1.11 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 23.2 | 12.1 | 22 | 23.9 | 11.4 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 14.5 | 8.54 | 5.87 | 11.9 | 10.7 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 22.1 | 9.07 | 11.1 | 17.4 | 12.7 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 1.16 | 3.03 | 10.8 | 6.45 | -1.35 |
Total Liabilities & Shareholders' Equity | 23.2 | 12.1 | 22 | 23.9 | 11.4 |
Total Common Shares Outstanding |